Molecular Partners AG 最近的每股收益为 $-0.23,未达预期 $-0.34 的预期。
Molecular Partners AG MLLCF 上一季度的收入表现如何?
Molecular Partners AG 上一季度的收入为 $-0.23
Molecular Partners AG 的收入预期是多少?
根据 位华尔街分析师的预测,Molecular Partners AG 的收入预期范围从 $ 到 $
Molecular Partners AG 的盈利质量评分是多少?
Molecular Partners AG 的盈利质量评分为 /。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
Molecular Partners AG 何时发布财报?
Molecular Partners AG 的下一份财报预计在 2026-06-10 发布
Molecular Partners AG 的预期收益是多少?
根据华尔街分析师的预测,Molecular Partners AG 的预期收益为 $0.0
Molecular Partners AG 是否超出收益预期?
Molecular Partners AG 最近的收益为 $0.0,未达预期 预期。
关键数据
前收盘价
$2.25
开盘价
$2.25
当日区间
$2.25 - $4.96
52周范围
$2.25 - $4.96
交易量
105
平均成交量
154
股息收益率
--
每股收益(TTM)
-2.02
市值
$185.5M
什么是 Molecular Partners AG?
Molecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The company is headquartered in Schlieren, Zuerich and currently employs 149 full-time employees. The company went IPO on 2014-10-22. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.